ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
会议论文

A randomized, open-label, multicenter, phase III study of high-dose vitamin C plus FOLFOX plus /- bevacizumab versus FOLFOX plus /- bevacizumab as first-line treatment in patients with unresectable metastatic colorectal cancer

Wang, F.; Xiao, J.; Zhang, Y.; Yuan, X.; He, M.; Fang, W.; Zhang, Y.; Wang, W.; Hu, X.; Ma, Z.; Yao, Y.; Zhuang, Z.; Zhou, F.; Ying, J.; Yuan, Y.; Zou, Q.; Guo, Z.; Wu, X.; Jin, Y.; Mai, Z.; Guo, Y.; Xu, R.佛山市第一人民医院; 广州医学院; 华中科技大学; 哈尔滨医科大学; 浙江大学; 苏州大学; 武汉大学; 中山大学; 6; 1
ESMO 24th World Congress on Gastrointestinal Cancer2022-6DOI: 10.1016/j.annonc.2022.04.416
10阅读
引用收藏
分享
相关
加载中…
  • A multicenter, randomized, open-label, phase III study of anlotinib plus CAPEOX versus bevacizumab plus CAPEOX as first-line therapy in patients with RAS/BRAF wild-type metastatic colorectal cancer
    Ding, K.; Liu, Y.; Song, Y.; Xu, D.; Li, J.; Wang, J.; Chen, X.; Lin, R.; Jiang, Y.; Zhang, Y.; Zhang, W.; Cheng, Y.; Wu, X.; Yuan, Y.Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), ELECTR NETWORK, 2022-09-09 To 2022-09-13.
  • A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ? Bevacizumab versus FOLFOX ? Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study)
    Wang, Feng; He, Ming -Ming; Xiao, Jian; Zhang, Yan-Qiao; Yuan, Xiang-Lin; Fang, Wei-Jia; Zhang, Yan; Wang, Wei; Hu, Xiao-Hua; Ma, Zhi-Gang; Yao, Yi-Chen; Zhuang, Zhi-Xiang; Zhou, Fu-Xiang; Ying, Jie-Er; Yuan, Ying; Zou, Qing-Feng; Guo, Zeng-Qing; Wu, Xiang-Yuan; Jin, Ying; Mai, Zong-Jiong; Wang, Zhi-Qiang; Qiu, Hong; Guo, Ying; Shi, Si -Mei; Chen, Shuang-Zhen; Luo, Hui-Yan; Zhang, Dong-Sheng; Wang, Feng-Hua*; Li, Yu-Hong; Xu, Rui-Hua*Clinical Cancer Research, 2022, 28(19): 4232-4239.被引 6
  • CPGJ602 plus mFOLFOX6 as first-line treatment for patients with KRAS/NRAS/BRAF wild-type metastatic colorectal cancer: A randomized phase II study.
    Xu, Jianming; Cao, Bangwei; Gu, Kangsheng; Bai, Yuxian; Li, Wei; Zhang, Jingdong; Liu, Caigang; Niu, Zuoxing; Zhang, Liangming; Zhong, Haijun; Luo, Suxia; Zhou, Jian-Wei; Liu, Tianshu; Gu, Yanhong; Lin, Jingguan; Deng, Yanhong; Chen, Chuangqi; Li, Yunfeng; Yang, Xiuli; Li, BihuiAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 2022-06-03 To 2022-06-07.
查看全部 →

会议信息

会议名称
ESMO 24th World Congress on Gastrointestinal Cancer
会议日期
2022-06-29 至 2022
论文集名
ANNALS OF ONCOLOGY
发表日期
2022-06
起止页码
S364-S364
DOI
10.1016/j.annonc.2022.04.416
资助标注
Sun Yat-sen University Clinical Research 5010 Program [2018014]; National Natural Science Foundation of China [81930065, 82173128]; Science and Technology Program of Guangdong [2019B020227002]; Science and Technology Program of Guangzhou [201904020046]
收录
ISTP · SCIE

作者

  • W

    Wang, F. (第一作者)

    sun yat sen univ

  • X

    Xiao, J.

    6 · sun yat sen univ

查看全部 22 位作者收起作者
  • Z

    Zhang, Y.

  • Y

    Yuan, X.

    huazhong univ sci & technol

  • H

    He, M.

  • F

    Fang, W.

    1 · zhejiang univ

  • Z

    Zhang, Y.

  • W

    Wang, W.

    peoples hosp foshan 1

  • H

    Hu, X.

    1 · guangxi med univ

  • M

    Ma, Z.

  • Y

    Yao, Y.

    sun yat sen univ

  • Z

    Zhuang, Z.

    2 · soochow univ

  • Z

    Zhou, F.

    wuhan univ

  • Y

    Ying, J.

    zhejiang canc hosp

  • Y

    Yuan, Y.

    2 · zhejiang univ

  • Z

    Zou, Q.

    guangzhou med univ

  • G

    Guo, Z.

    fujian canc hosp

  • W

    Wu, X.

    sun yat sen univ

  • J

    Jin, Y.

    sun yat sen univ

  • M

    Mai, Z.

  • G

    Guo, Y.

    sun yat sen univ

  • X

    Xu, R.

    sun yat sen univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417